Ryan Sjostrom Email & Phone Number

Gaithersburg, Maryland, Us

Chiyoda-Ku, Tokyo, Jp

. Development of therapeutic category assessments outlining the minimally viable global value proposition for payers (public, private) and payer archetypes (budget impact, cost effectiveness, cost utility, free pricing etc.) including the key criteria needed to support a commercial case. Establishment of a consistent, aligned framework that allows for early commercial input across the R&D centres. Ensuring that the R&D organizations understand what it will take to be commercially successful in different indications and prioritizing areas where chances of regulatory and reimbursement success are high. Assessment of proof of concept opportunities and future clinical trial designs for potential market access risks and/or opportunities to optimize coverage and patient access (e.g., formulation, dosing, outcomes, potential data that would support positive coverage determinations, choice of comparator, potential cost-offset data). Assessment and/or development of assessment tools/methodologies to build an enduring information bank of opportunities/challenges. Scenario planning to account for existing and potential future policies that may impact payer perspectives. Cross functional collaboration providing learnings and insights based on assets further in development and recently launched to further inform early pipeline focus and decision making. Inform portfolio optimization of early discovery molecules based on payer and commercial perspectives

Princeton, Nj, Us

• Head of Otsuka’s late-stage asset commercialization unit, valued at ~ $1.7B based on forecasted gross sales• Market access pricing, contracting, and mature-products commercial strategy (CNS and Rare Disease)• Develop comprehensive strategic plans across therapy areas, product portfolio, and life-cycle management programs • Supply, channel, shared services, and GPV integration

Princeton, Nj, Us

• Commercial chair for global products development committee • Commercial chair for mature products development committee• Developing long-term growth strategies through BD, innovation, portfolio, and LCM planning • Working to identify alternative revenue streams, adjacent and near-term business opportunities and collaborations

San Francisco, California, Us

• Core member in Otsuka Alliances, and US Market Access representative for global assessments and program valuations• Inform and direct product development programs based on market opportunities, customer needs, and industry trends • Lead the development of the market access business and commercial strategy• Key stakeholder and contributor in evaluating business development opportunities, negotiating deal-sheet terms and conditions, and developing strategic synergies across the organization• Commercial Leadership Team member, focused on driving efforts to align strategic initiatives across Otsuka, affiliates, and alliances• Focused on increasing Otsuka’s market presence to increase opportunities for collaborations and partnerships • Member of the Global Marketing, Global Pharmaceutical Strategy Business, and Global IRA task-force business units

San Francisco, California, Us

• Market access engagement and contracting with national payers, PBMs and GPOs. Responsible for delivering profitable access and managing gross-to-net thresholds • Negotiate agreements and deal sheet terms, contract redlining and review, auditing, and due diligence• National Payor, PBM, and GPOs. Responsible for the single largest account valued at 35% of Otsuka business. • Pre-launch and portfolio contracting and strategy development• Project lead for modeling organizational impact from MDRP, HR3, HR19, NBPP and HHS rules and regulations• Organizational strategy development and market access contracting/tactical recommendations for new product launches/assets

Bagsværd, Dk

Developing and implementing the commercial strategy and long-term planning for the diabetes business unit through integrating: long-term forecasting, franchise planning, and portfolio management. The diabetes business unit is the largest contributor and growth driver for Novo Nordisk A/S • >50% global contribution, 6.2% CAGR, $7.2B annual revenue – single largest contributing business unit to Novo Nordisk A/S• Optimize and anchor commercial strategy within Corporate, Global Therapy Area, Franchise, and Enterprise business needs.• Commercial business plans, portfolio strategy, and market development• Align LTFs, pipeline, BD ventures, and future assets into an integrated commercial plan• Address internal gaps and external threats relative to the diabetes business unit• Strategic tradeoffs, investments, and portfolio prioritization

Bagsværd, Dk

• Responsible for developed and leading the national strategy, operations, and execution for the integrated account team• @ 2.5B annual revenue, the health system channel was the largest, fastest growing, and greatest contributing channel• Created and developed the integrated account team: account managers, clinical educators, specialty sales• Designed customer engagement strategies, training and development, and competency assessments• P&L, impact and ROI analysis, field sizing and implementation • IC plan development – market, AB, and product forecasting

Bagsværd, Dk

• Lead the national strategy, marketing, operations, and execution for the clinical education program (2nd largest field team)• Developed and lead hybrid Health System account development field teams• Full P&L responsibility including impact analysis, AB forecasting, marketing and field budgets, goals and IC• Integrated real-time data and real-world evidence into execution and deployment decisions • Redesigned incentive program to align to key quality drivers (NCQA/HEDIS, MACRA/MIPS, 5-Star measures)• Training & Development including: CEUs, assessments, specialty programs, POAs and training tracks

Bagsværd, Dk

• Field Deployment and Assessments: Lead the impact analysis, sizing, deployment and budget modeling for sales and alternative field teams including the clinical education program• Organizational assessment, design and deployment• Forecasting, AB and IC plan development• Market basket, call plan, and impact modeling• Budget and P&L management

Bagsværd, Dk

• Lead the global future field force project developing new and innovative business and engagement models• Development of alternative customer engagement and management models• Future field force modeling and assessment for agile market response• Remote and alternative provider and patient support programs• In-depth analysis pharma, customer, and patient perceptions

Bagsværd, Dk

Endocrinology Business ManagerNew product market launch: Field contributor for the specialty launch/ roll-out within key health systems and integrated delivery networks delivering $200M first-year launch (235% to plan).• KOL development, advocacy groups, and health system launch planning• Alliances, advocacy and market shaping: AACE, ENDO, ADA• Delivered >40% of total value during second market entry and new class launch for organizationInstitution Business ManagerContract management: Responsible for leading an institution account specialty team with direct contracting and GPO pricing for health systems, teaching institutions, regional payers, IHS and VAs• Led workstream to operationalize dividing business units into institutional (non-retail) and specialty market segments• Leadership development program participant (previously rotated through field sales and RFT)

Basel, Baselstadt, Ch

• Diabetes and cardiovascular sales• Specialty accounts and endocrinology

Brentford, Middlesex, Gb

• Sales and account executive covering diabetes and cardiovascular accounts, and direct-buy/contracting with vaccines.• Specialty sales: diabetes and cardiovascular• Account manager: vaccines, buy-n-bill, GPO and direct contracting, pediatric centers, hospitals, teaching institutions• Sales Representative

Rockford, Illinois, Us

• Manager for the human embryology laboratory department. • Oversaw laboratory services in coordination with the reproductive endocrinology and genetic programs• Certified Embryologist trained through UIC College of Medicine and Rockford Fetal-Maternal Medicine• Reproductive and genetic counseling

Rockford, Illinois, Us

• Quality coordinator and chair of the quality improvement and oversight committee• Developed a system-wide training program to reduce nosocomial infections and contaminated blood draws• Bench microbiologist: bacterial and fungal diagnosis – reference laboratory

Executive Education

Mba, Marketing And Finance

Certificate, Developmental Embryology And Biology

Bachelor'S Degree, Medical Microbiology And Bacteriology